ILAE-Europe
EpiCARE
EpiCARE -- a European Reference Network for Rare and Complex Epilepsies -- connects 28 expert centres in 13 Eruopean countries with the aim of aiding the diagnosis and treatment of rare epilepsy patients by using e-tools and cross-country e-consultance. EU member states without EpiCARE centres can nominate affiliated partners to join the network.
Monthly EpiCARE Webinars: Free monthly webinars with topics related to rare and complex epilepsies and research
EpiCARE Designation of affiliated partners
Award Winners Announced
ILAE-Europe is pleased to announce the recipients of the European Awards 2018. The awards were presented during the Welcome Ceremony of the 13th ECE on Sunday 26th August.
European Epileptology Award - Emilio Perucca (Italy)
European Young Investigator Award - Birgit Frauscher (Austria/Canada)
European Young Investigator Award - Sylvain Rheims (France)
European Epilepsy Education Award - Kristina Malmgren (Sweden)
European Epilepsy Service Award - Finola Quinn (Ireland)
2020 Course Applications
European Chapter Executives are invited to submit applications for funding of courses/symposia sponsored by ILAE-Europe during 2020.
Read letter to European Chapters
Procedure for endorsing educational activities not endorsed by the ILAE
Application for Requesting ILAE Endorsement of an Educational Activity
Latest News
Clinical Research
Prevalence of MRI abnormalities in people with epilepsy in rural China
More than one-third of people with chronic epilepsy in rural China have potentially epileptogenic lesions identifiable on brain MRI, with two-thirds fulfilling the definition of pharmacoresistance. These findings highlight the magnitude of the unmet needs for epilepsy surgery in China.
17 September, 2020
About ILAE
Please complete new survey: medical treatment in childhood epilepsy
Please take a few minutes to complete the new survey and share it with your colleagues. The survey looks at current treatment practices in 6 typical early life epilepsy scenarios. Our aim is not only to show first and second line treatment preferences, but also to illustrate that we commonly use off-label drugs in childhood epilepsies.
9 September, 2020
Clinical Research
Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures
This paper reviews recent evidence from human and experimental models of absence seizures and concludes that “Together, these novel clinical and experimental findings bring about paradigm-shifting views of our understanding of absence seizures and demand careful choice of initial monotherapy and continuous neuropsychiatric evaluation of affected children”
31 August, 2020
Clinical Research
Mortality in patients with psychogenic nonepileptic seizures
Patients diagnosed with PNES have a SMR 2.5 times above the general population, dying at a rate comparable to those with drug-resistant epilepsy. This emphasizes the importance of prompt diagnosis, identification of risk factors, and implementation of appropriate strategies to prevent potential avoidable deaths.
24 August, 2020
World News
In memory Anthony Mulenga Zimba
It is with great sadness that IBE announces the death of its esteemed Treasurer, Anthony Mulenga Zimba. A victim of COVID-19, Anthony passed away in hospital in Lusaka, Zambia, on the morning of Sunday 9th August. Anthony had a long history of service to IBE, He worked tirelessly on behalf of people with epilepsy and those who care for them. His particular focus was on his beloved Africa and, as a result of his efforts, many IBE chapters in the region were supported through the IBE Promising Strategies Program in a range of projects aimed at improving their quality of life through training, advocacy and employment opportunities.
11 August, 2020
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community